Implementation of Team Clinic for Type 2 Diabetes (TCT2)
NCT ID: NCT06923046
Last Updated: 2025-10-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
160 participants
INTERVENTIONAL
2025-08-14
2027-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question\[s\] it aims to answer are:
* Is shared medical appointments an acceptable care delivery model for this population?
* Does shared medical appointment improve psychosocial outcomes for this population?
Participants will attend quarterly clinic appointments and group activities and take surveys. Researchers will compare this intervention to standard of care.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Designing Team Clinic for Youth With Type 2 Diabetes
NCT06658743
Improving Transition Care for Adolescents and Young Adults With Type 1 Diabetes
NCT05639088
Diabetes Care Management Compared to Standard Diabetes Care in Adolescents and Young Adults With Type 1 Diabetes
NCT01351857
Type 2 Continuous Glucose Monitoring Academy
NCT06516640
Shared Medical Appointments to Improve Outcomes in Adolescents With Type 1 Diabetes
NCT02547311
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Care
Multidisciplinary team based care every 3 months.
Standard of Care
Multidisciplinary team based care every 3 months.
Shared Medical Appointment
Participants will attend 4 quarterly appointments. In addition to time with their clinician, they will also have group activities that address relevant topics.
Shared Medical Appointments
Participants will attend 4 quarterly appointments. In additionto time with their clinician, they will also have groupactivities that address relevant topics.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard of Care
Multidisciplinary team based care every 3 months.
Shared Medical Appointments
Participants will attend 4 quarterly appointments. In additionto time with their clinician, they will also have groupactivities that address relevant topics.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* English speaking youth
* Youth prescribed medication for type 2 diabetes
* English or Spanish speaking caregivers
* Age 12 to 18 years old at the time of enrollment
* Willingness to attend clinic visits and participate in group session (if randomized to Team Clinic), complete surveys
* Has a child between the ages of 12 and up to 18 at the time of enrollment who receives care for T2D in the endocrinology clinic at CHLA. The child must provide consent/assent to participate as a youth participant.
* Speaks English of Spanish. Over 95% of our T2D population speaks one of those two languages. Our facilitator will be bilingual in English and Spanish. It is not feasible for the facilitator to also speak another language. Having a language interpreter for discussion groups will affect the dynamics and flow of the group session
* Willingness to participate in group session (if their child is randomized to Team Clinic) and complete surveys.
Exclusion Criteria
* Pregnancy
* Inability or unwillingness of individual or legal guardian/representative to give written informed assent/consent
Caregiver/Parents Participants
-Inability or unwillingness of individual to give written informed consent
12 Years
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Francisco
OTHER
American Diabetes Association
OTHER
Children's Hospital Los Angeles
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
lily chao
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lily Chao, MD
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital Los Angeles
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital Los Angeles
Los Angeles, California, United States
University of California, San Francisco
San Francisco, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHLA-25-00070
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.